Astera Labs (NASDAQ:ALAB) Price Target Cut to $258.00 by Analysts at Susquehanna

Astera Labs (NASDAQ:ALAB) had its price objective decreased by Susquehanna from $310.00 to $258.00 in a report issued on Wednesday morning,Benzinga reports. Susquehanna currently has a neutral rating on the stock.

Several other research analysts also recently weighed in on ALAB. Northland Securities upgraded Astera Labs from a “market perform” rating to an “outperform” rating and set a $315.00 price target for the company in a research note on Wednesday. Zacks Research lowered shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 5th. Royal Bank Of Canada upped their target price on shares of Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 5th. Morgan Stanley raised their target price on shares of Astera Labs from $240.00 to $335.00 and gave the company an “overweight” rating in a research note on Monday, August 3rd. Finally, Citigroup downgraded shares of Astera Labs from a “buy” rating to a “hold” rating in a report on Friday, October 9th. Twelve investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $318.00.

Astera Labs Stock Down 4.4%

Shares of Astera Labs stock opened at $223.27 on Wednesday. The company has a market capitalization of $38.73 billion, a price-to-earnings ratio of 88.95 and a beta of 3.85. The stock’s 50-day simple moving average is $304.94 and its 200-day simple moving average is $255.78. Astera Labs has a 52 week low of $97.89 and a 52 week high of $499.48.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, November 3rd. The company reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.19 by $0.13. The firm had revenue of $584.90 million during the quarter, compared to analysts’ expectations of $550.78 million. Astera Labs had a return on equity of 27.30% and a net margin of 29.64%. The firm’s revenue was up 153.6% on a year-over-year basis. During the same quarter last year, the business posted $0.49 earnings per share. On average, equities analysts expect that Astera Labs will post 2.71 earnings per share for the current year.

Insider Activity at Astera Labs

In other Astera Labs news, General Counsel Philip Mazzara sold 6,801 shares of the firm’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the completion of the transaction, the general counsel owned 96,542 shares in the company, valued at $32,872,551. This trade represents a 6.58% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Sanjay Gajendra sold 90,630 shares of Astera Labs stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief operating officer directly owned 1,119,038 shares in the company, valued at approximately $380,864,583.30. The trade was a 7.49% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 396,059 shares of company stock valued at $123,408,470 in the last 90 days. 10.40% of the stock is currently owned by insiders.

Institutional Trading of Astera Labs

Hedge funds have recently modified their holdings of the company. BlackRock Inc. purchased a new position in shares of Astera Labs in the 2nd quarter worth $6,609,581,000. Atreides Management LP increased its holdings in shares of Astera Labs by 108.9% in the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after buying an additional 1,754,593 shares during the last quarter. Van ECK Associates Corp raised its position in shares of Astera Labs by 20.0% during the 2nd quarter. Van ECK Associates Corp now owns 2,237,961 shares of the company’s stock valued at $1,080,980,000 after buying an additional 373,545 shares in the last quarter. Bank of America Corp DE purchased a new stake in shares of Astera Labs during the 2nd quarter valued at about $1,061,791,000. Finally, Amundi raised its position in shares of Astera Labs by 77.9% during the 1st quarter. Amundi now owns 1,880,830 shares of the company’s stock valued at $206,139,000 after buying an additional 823,477 shares in the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs News Roundup

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q3 earnings of $1.32 per share beat the $1.19 consensus, while revenue of $584.9 million exceeded estimates and rose 153.6% year over year. Scorpio switches, including the X-Series, were a key growth driver. Article: Astera Labs Q3 Earnings and Revenues Beat Estimates
• Positive Sentiment: Management forecast Q4 revenue of $730 million to $750 million, citing AI connectivity demand. Expansion into optical connectivity, memory and rack-scale AI systems may provide additional growth opportunities. Article: ALAB Q3 Earnings Call Highlights Scorpio Ramp and New Growth Engines
• Neutral Sentiment: Analyst opinions were mixed: Northland upgraded ALAB to Outperform and Morgan Stanley raised its price target, while several firms lowered targets; RBC maintained an Outperform rating. Article: Northland Securities stock recommendations
• Negative Sentiment: Shares fell despite the earnings beat, suggesting results and guidance may not have been enough to satisfy expectations. Analysts flagged a premium valuation, rising costs, reliance on a limited number of customers and competition—particularly Marvell’s optical push—as risks to future growth. Article: Astera Labs Stock Falls Despite Strong Earnings. Its Growth Story Is Intact.

Astera Labs Company Profile

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.